Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model

Neuropsychopharmacology. 2022 Aug;47(9):1733. doi: 10.1038/s41386-022-01345-x.
No abstract available

Publication types

  • Published Erratum